Glenmark launches biosimilar of Adalimumab
The drug will be used for the treatment of plaque psoriasis and rheumatoid arthritis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India, Sri Lanka to sign MoU on traditional systems of medicine and homoeopathy
The financial resources necessary to conduct activities under the MoU will be met from the existing allocated budget under this…
Bharat Biotech’s Typbar TCV pre-qualified by WHO
Typbar TCV is the first typhoid vaccine, clinically proven to be administered to children from six months of age to adults and…
Oviya MedSafe to conduct workshop for pharmacovigilance officers in charge in Mumbai
The event will be held at Hotel Kohinoor Continental
Pharma exports witness dip in 2016-17
According to the government, the dip in pharma exports was due to shifting of mfg bases, market consolidation
Recipharm acquires remaining shares in Nitin Lifesciences
The acquisition will be completed in two steps
Hetero launches biosimilar Adalimumab
The product under the brand name ‘Mabura’ in India, will be manufactured in Hyderabad
NPPA fixes retail prices of 14 formulations
NPPA has asked the manufacturers to furnish quarterly return to the authority regarding production/import and sale of the products
PMBJP selling drugs up to 96 per cent cheaper than branded equivalents
India has 3,033 functional PMBJP Kendras
US FDA approves Mylan’s copy of Allergan’s vaginal cream
Vaginal atrophy results in thinning and inflammation of the vaginal walls due to less estrogen